The comparison highlights SUNVOU-CA2122's versatility, offering more advanced features in terms of biomarkers, quality control options, and calibration techniques compared to NIOX VERO. The data shows that SUNVOU-CA2122 provides quicker, more efficient, and broader measurements across different biomarker ranges and sampling options.

The 1+2 breath test device offers multiple sampling methods (online, offline, tidal) for different age groups and airway measurements for large, small, and upper airways using various biomarkers like NO, CO, and H2S. It addresses a wide range of inflammatory conditions, including asthma, COPD, and rhinitis. The device includes advanced quality control options such as qualified user checks, standard gas usage, and self-calibration with patented technology.

From 2008 to 2021, breath testing guidelines evolved from the initial "1" Guideline featuring NIOX MINO and FeNO50, to the more comprehensive "1+2" Guidelines. These later iterations, including contributions from ATS, ERS, and Chinese expert consensus, added measurements like FeNO200, CaNO, and FnNO10, expanding the scope of airway inflammation diagnostics.

#Living Healthier with Asthma: Your Ultimate Device to the Rescue

A FeNO device is a valuable tool for diagnosing comorbidities associated with asthma by measuring airway inflammation at various flow rates—FeNO50, FeNO100, and FeNO200—each linked to different regions of the airways and specific comorbidities.

Alongside this chronic condition, individuals often experience what's termed as 'asthma comorbidities' - additional health conditions that can exacerbate their asthma symptoms.

Our device assists in choosing the suitable medication - usually inhaled corticosteroids (ICS) – which serves as a powerful anti-inflammatory treatment for asthma by suppressing airway inflammation.

Understanding the degree of airway inflammation by testing Fractional Exhaled Nitric Oxide (FeNO) can significantly aid in streamlining your asthma treatment strategy. It specifically assists in personalizing the type and dosage of medication for each patient.

Explore the advantage of FeNO testing, a Fractional Exhaled Nitric Oxide test, playing a crucial role in diagnosing and managing asthma, and related health conditions.

Discover the Advantages of FENO Testing: Encounter a breath of fresh air in asthma management with the Fractional Exhaled Nitric Oxide Test (FENO).